Cargando…
ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas
BACKGROUND: Gliomas are the most lethal primary brain tumors and are still a major therapeutic challenge. Oncolytic virus therapy is a novel and effective means for glioma. However, little is known about gene expression changes during this process and their biological functions on glioma clinical ch...
Autores principales: | Li, Jinchuan, Zhang, Yi, Qu, Zhizhao, Ding, Rui, Yin, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358688/ https://www.ncbi.nlm.nih.gov/pubmed/35959373 http://dx.doi.org/10.3389/fcimb.2022.956801 |
Ejemplares similares
-
A novel oncolytic virus-based biomarker participates in prognosis and tumor immune infiltration of glioma
por: Hao, Zheng, et al.
Publicado: (2023) -
ORFV infection enhances CXCL16 secretion and causes oncolysis of lung cancer cells through immunogenic apoptosis
por: Wang, Ruixue, et al.
Publicado: (2022) -
A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology
por: Yin, Xiaofeng, et al.
Publicado: (2022) -
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
por: Liu, Junfeng, et al.
Publicado: (2023) -
High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma
por: Zhang, Yi, et al.
Publicado: (2023)